This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pietro Maggioni, A. Search for Related Content PubMed Articles by Pietro Maggioni, A. Social Bookmarking                         What's this?

Symptomatic despite Multiple Drug Therapy: Where do you Turn Next?

ANMCO Research Centre, Florence, Italy, maggioni{at}anmco.it

Clinicians may be reluctant to implement evidence-based guideline recommendations because they believe that patients with chronic heart failure (CHF) who are enrolled into clinical trials are not truly representative of those seen in routine practice. Moreover, there may also be perceived safety issues associated with polypharmacy in patients with CHF. Clinicians should strive to implement guideline recommendations for the management of CHF to ensure optimal patient outcome in routine clinical practice.

This case report demonstrates that symptom control may require a large number of pharmacological treatments, to be administered in accordance with guidelines.

Key Words: Chronic heart failure • Polypharmacy • Angiotensin Receptor blocker

Journal of Renin-Angiotensin-Aldosterone System, Vol. 6, No. 2 suppl, S13-S14 (2005)
DOI: 10.1177/14703203050060020501


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?